Annual Short Term Debt
$1.14 M
+$326.50 K+39.96%
30 April 2024
Summary:
ImmunoPrecise Antibodies annual short term debt is currently $1.14 million, with the most recent change of +$326.50 thousand (+39.96%) on 30 April 2024. During the last 3 years, it has risen by +$340.50 thousand (+42.40%). IPA annual short term debt is now -45.57% below its all-time high of $2.10 million, reached on 30 April 2019.IPA Short Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Short Term Debt
$3.42 M
+$382.80 K+12.61%
31 October 2024
Summary:
ImmunoPrecise Antibodies quarterly short term debt is currently $3.42 million, with the most recent change of +$382.80 thousand (+12.61%) on 31 October 2024. Over the past year, it has increased by +$2.73 million (+395.49%). IPA quarterly short term debt is now at all-time high.IPA Quarterly Short Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
IPA Short Term Debt Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +40.0% | +395.5% |
| 3 y3 years | +42.4% | +90.0% |
| 5 y5 years | -45.6% | +43.0% |
IPA Short Term Debt High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -35.6% | +42.4% | at high | +442.9% |
| 5 y | 5 years | -45.6% | +42.4% | at high | +468.9% |
| alltime | all time | -45.6% | >+9999.0% | at high | >+9999.0% |
ImmunoPrecise Antibodies Short Term Debt History
| Date | Annual | Quarterly |
|---|---|---|
| Oct 2024 | - | $3.42 M(+12.6%) |
| July 2024 | - | $3.04 M(+165.4%) |
| Apr 2024 | $1.14 M(+40.0%) | $1.14 M(-13.3%) |
| Jan 2024 | - | $1.32 M(+91.2%) |
| Oct 2023 | - | $689.80 K(-12.3%) |
| July 2023 | - | $786.10 K(-3.8%) |
| Apr 2023 | $817.10 K(-54.0%) | $817.10 K(-15.3%) |
| Jan 2023 | - | $964.50 K(+13.6%) |
| Oct 2022 | - | $848.70 K(+34.8%) |
| July 2022 | - | $629.50 K(-64.6%) |
| Apr 2022 | $1.78 M(+121.2%) | $1.78 M(-0.3%) |
| Jan 2022 | - | $1.78 M(-1.0%) |
| Oct 2021 | - | $1.80 M(-2.3%) |
| July 2021 | - | $1.84 M(+129.3%) |
| Apr 2021 | $803.10 K(-60.9%) | $803.10 K(+12.9%) |
| Jan 2021 | - | $711.30 K(+1.1%) |
| Oct 2020 | - | $703.30 K(+17.1%) |
| July 2020 | - | $600.80 K(-70.7%) |
| Apr 2020 | $2.05 M(-2.3%) | $2.05 M(-16.8%) |
| Jan 2020 | - | $2.47 M(+3.2%) |
| Oct 2019 | - | $2.39 M(-2.5%) |
| July 2019 | - | $2.45 M(+16.7%) |
| Apr 2019 | $2.10 M(+1282.2%) | $2.10 M(+2632.0%) |
| Jan 2019 | - | $76.90 K(-20.3%) |
| Oct 2018 | - | $96.50 K(-64.8%) |
| July 2018 | - | $274.10 K(+80.3%) |
| Date | Annual | Quarterly |
|---|---|---|
| Apr 2018 | $152.00 K(+182.0%) | $152.00 K(+115.9%) |
| Jan 2017 | - | $70.40 K(+70.5%) |
| Sept 2016 | - | $41.30 K(-28.5%) |
| June 2016 | - | $57.80 K(+0.3%) |
| Mar 2016 | - | $57.60 K(+6.9%) |
| Dec 2015 | $53.90 K(-15.4%) | - |
| Dec 2015 | - | $53.90 K(-2.2%) |
| Sept 2015 | - | $55.10 K(-7.6%) |
| June 2015 | - | $59.60 K(+2.2%) |
| Mar 2015 | - | $58.30 K(-8.5%) |
| Dec 2014 | $63.70 K(-44.8%) | - |
| Dec 2014 | - | $63.70 K(-2.5%) |
| Sept 2014 | - | $65.30 K(-43.3%) |
| June 2014 | - | $115.20 K(+3.6%) |
| Mar 2014 | - | $111.20 K(-3.6%) |
| Dec 2013 | $115.40 K(+129.4%) | - |
| Dec 2013 | - | $115.40 K(+35.3%) |
| Sept 2013 | - | $85.30 K(+1.5%) |
| June 2013 | - | $84.00 K(-3.0%) |
| Mar 2013 | - | $86.60 K(+72.2%) |
| Dec 2012 | $50.30 K(+2.7%) | - |
| Dec 2012 | - | $50.30 K(+2.7%) |
| Dec 2011 | $49.00 K(+920.8%) | - |
| Dec 2011 | - | $49.00 K(+860.8%) |
| Mar 2003 | - | $5100.00(+6.3%) |
| Dec 2002 | $4800.00 | - |
| Dec 2002 | - | $4800.00 |
FAQ
- What is ImmunoPrecise Antibodies annual short term debt?
- What is the all time high annual short term debt for ImmunoPrecise Antibodies?
- What is ImmunoPrecise Antibodies annual short term debt year-on-year change?
- What is ImmunoPrecise Antibodies quarterly short term debt?
- What is the all time high quarterly short term debt for ImmunoPrecise Antibodies?
- What is ImmunoPrecise Antibodies quarterly short term debt year-on-year change?
What is ImmunoPrecise Antibodies annual short term debt?
The current annual short term debt of IPA is $1.14 M
What is the all time high annual short term debt for ImmunoPrecise Antibodies?
ImmunoPrecise Antibodies all-time high annual short term debt is $2.10 M
What is ImmunoPrecise Antibodies annual short term debt year-on-year change?
Over the past year, IPA annual short term debt has changed by +$326.50 K (+39.96%)
What is ImmunoPrecise Antibodies quarterly short term debt?
The current quarterly short term debt of IPA is $3.42 M
What is the all time high quarterly short term debt for ImmunoPrecise Antibodies?
ImmunoPrecise Antibodies all-time high quarterly short term debt is $3.42 M
What is ImmunoPrecise Antibodies quarterly short term debt year-on-year change?
Over the past year, IPA quarterly short term debt has changed by +$2.73 M (+395.49%)